Organoids for toxicology and genetic toxicology: applications with drugs and prospects for environmental carcinogenesis
Mutagenesis · 04.05.2022 · 37 (2) · 143-154
DOI: 10.1093/mutage/geab023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mutagenesis, online erschienen am 19.06.2021. Verfasst von Angela L Caipa Garcia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical, Environmental and Forensic Sciences, School of Population Health and Environmental Sciences, King's College London, London,…. Hauptthemen laut MEDLINE: Organoids, Pluripotent Stem Cells. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Department of Health, Cancer Research UK.
Abstract (Originalsprache)
Advances in three-dimensional (3D) cell culture technology have led to the development of more biologically and physiologically relevant models to study organ development, disease, toxicology and drug screening. Organoids have been derived from many mammalian tissues, both normal and tumour, from adult stem cells and from pluripotent stem cells. Tissue organoids can retain many of the cell types and much of the structure and function of the organ of origin. Organoids derived from pluripotent stem cells display increased complexity compared with organoids derived from adult stem cells. It has been shown that organoids express many functional xenobiotic-metabolising enzymes including cytochrome P450s (CYPs). This has benefitted the drug development field in facilitating pre-clinical testing of more personalised treatments and in developing large toxicity and efficacy screens for a range of compounds. In the field of environmental and genetic toxicology, treatment of organoids with various compounds has generated responses that are close to those obtained in primary tissues and in vivo models, demonstrating the biological relevance of these in vitro multicellular 3D systems. Toxicological investigations of compounds in different tissue organoids have produced promising results indicating that organoids will refine future studies on the effects of environmental exposures and carcinogenic risk to humans. With further development and standardised procedures, advancing our understanding on the metabolic capabilities of organoids will help to validate their use to investigate the modes of action of environmental carcinogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Analytical, Environmental and Forensic Sciences, School of Population Health and Environmental Sciences, King's College London, London, SE1 9NH, UK.
ORCID-Profile: Volker M Arlt, David H Phillips
Förderung
- Medical Research Council
- Department of Health
- Cancer Research UK
- UK Medical Research Council
- National Institute for Health Research
Zitieren
APA
Caipa Garcia, A. L., Arlt, V. M., & Phillips, D. H. (2022). Organoids for toxicology and genetic toxicology: applications with drugs and prospects for environmental carcinogenesis. Mutagenesis, 37(2), 143-154. https://doi.org/10.1093/mutage/geab023
Vancouver
Caipa Garcia AL, Arlt VM, Phillips DH. Organoids for toxicology and genetic toxicology: applications with drugs and prospects for environmental carcinogenesis. Mutagenesis. 2022;37(2):143-154. doi:10.1093/mutage/geab023
BibTeX
@article{CaipaGarcia2022,
author = {Caipa Garcia, Angela L and Arlt, Volker M and Phillips, David H},
title = {Organoids for toxicology and genetic toxicology: applications with drugs and prospects for environmental carcinogenesis},
journal = {Mutagenesis},
year = {2022},
volume = {37},
number = {2},
pages = {143--154},
doi = {10.1093/mutage/geab023}
}
EUVIMED